Notice bibliographique
- Notice
Type(s) de contenu et mode(s) de consultation : Texte noté : électronique
Titre(s) : Dubois' lupus erythematosus and related syndromes [Texte électronique] / [edited by] Daniel J Wallace, Bevra Hannahs Hahn
Édition : 8th ed.
Publication : Philadelphia, PA : Elsevier/Saunders, cop. 2013
Description matérielle : 1 ressource dématérialisée
Note(s) : Revised edition of: Dubois' lupus erythematosus / editors, Daniel J. Wallace, Bevra
Hannahs Hahn. 7th ed. c2007. - Includes bibliographical references and index
This book first published in 1966, for the past forty years, it has distinguished
itself internationally as reference on lupus and related diseases. For rheumatologists
and internal medicine practitioners who need a comprehensive clinical reference on
systemic lupus erythematosus (SLE) and related disorders, a complete arsenal of information
on SLE, connective tissue diseases, and the antiphospholipid syndromes. Authoritative,
comprehensive content that balances basic science with clinical expertise. Fundamental
images of lupus rashes, graphs, algorithms, and copious drug dosing and differential
diagnosis tables. Includes a patient's guide with glossary and a complication of resources
for patients and health professionals. First time published in full color. 75% new
contributors. 10 chapters new to this edition. Sleeker, trimmed-down text. Addition
of Michael Weisman, Ronald Van Vollenhoven, Nan Shen, and David Isenberg as Associate
editors
Autre(s) auteur(s) : Wallace, Daniel Jeffrey (1949-....)
Hahn, Bevra. Fonction indéterminée
Dubois, Edmund L.. Fonction indéterminée
Autre(s) forme(s) du titre :
- Autre forme du titre : Lupus erythematosus and related syndromes
Sujet(s) : Lupus érythémateux aigu disséminé
Indice(s) Dewey :
616.772 (23e éd.) = Lupus érythémateux disséminé (médecine)
Identifiants, prix et caractéristiques : ISBN 9781437718935
Identifiant de la notice : ark:/12148/cb44660684t
Notice n° :
FRBNF44660684
(notice reprise d'un réservoir extérieur)
Table des matières : Section I: What is lupus?chapter 1 ; Definition and classification of lupus and lupus-related
disorders /Jinoos Yazdany and Maria Dall'Erachapter 2 ; The epidemiology of lupus
/S. Sam Lim and Christina Drenkard
Section II: The pathogenesis of lupuschapter 3 ; The pathogenesis of SLE /Bevra H.
Hahnchapter 4 ; Genetics of human SLE /Yun Deng and Betty P. Tsaochapter 5 ; Epigenetics
of lupus /Nan Shen, Dong Liang, Yuajia Tang, and Yuting Qinchapter 6 ; The innate
immune system in SLE /Lukas Bossaller and Ann Marshak-Rothsteinchapter 7 ; Cytokines
and interferons in lupus /Mary K. Crow, Timothy B. Niewold, and Kyriakos A. Kirouchapter
8 ; The structure and derivation of antibodies and autoantibodies /Giovanni Franchin,
Yong-Rui Zou, and Berry Diamondchapter 9 ; T cells /José C. Crispin and George C.
Tsokoschapter 10 ; Regulatory cells in SLE /Antonio la Cavachapter 11 ; Apoptosis,
necrosis, and autophagy /Keith B. Elkonchapter 12 ; Abnormalities in immune complex
clearance and Fcy receptor function /Jane E. Salmon and Robert P. Kimberlychapter
13 ; Neural-immune interactions: principles and relevance to SLE /Cherie L. Butts
and Esther M. Sternbergchapter 14 ; Complement and SLE /Chau-Ching Liu, Susan Man
Section III: Autoantibodieschapter 19 ; Immune tolerance defects in lupus /Ram Raj
Singh, Shweta Dubey, and Julia Pinkhasovchapter 20 ; Autoantibodies /edited by David
Isenberg ; Antibody structure, function, and production /Jessica Manson ; Antibodies
to DNA, histones, and nucleosomes /Anisur Rahman, Jessica Manson, and David Isenberg
; Anti-lipoprotein and anti-endothelial cell antibodies /Anisur Rahman ; Anti-C1q
antibodies /C.G.M. Kallenberg ; Antibodies against the extractable nuclear antigens
RNP, Sm, Ro/SSA, and La/SSB /Gabriela Riemekasten and Falk Hiepechapter 21 ; Autoantigenesis
and antigen-based therapy and vaccination in SLE /Ram Raj Singh, Julia Pinkhasov,
Priti Prasad, and Shweta Dubey
Section IV: Clinical aspects of SLEchapter 22 ; Overview and clinical presentation
/Andrea Hinojosa-Azaola and Jorge Sánchez-Guerrerochapter 23 ; Pathomechanisms of
cutaneous lupus erythematosus /Jan P. Dutzchapter 24 ; Skin disease in cutaneous lupus
erythematosus /Benjamin F. Chong and Victoria P. Werthchapter 25 ; The musculoskeletal
system and bone metabolism /Sandra V. Navarra and Tito P. Torralbachapter 26 ; Pathogenesis
and treatment of atherosclerosis in lupus /Maureen McMahon, Brian Skaggs, and Jennifer
Grossmanchapter 27 ; Cardiopulmonary disease in SLE /Guillermo Ruiz-Irastorza and
Munther Khamashtachapter 28 ; Pathogenesis of the nervous sytem /Cynthia Aranow, Betty
Diamond, and Meggan Mackaychapter 29 ; Clinical aspects of the nervous system /Sterling
G. Westchapter 30 ; Psychopathology, neurodiagnostic testing, and imaging /John G.
Hanly, Antonina Omisade, and John D. Fiskchapter 31 ; Ocular, aural, and oral manifestations
/James T. Rosenbaum, Dennis R. Trune, Andre Barkhuizen,
Section V: The reproductive system and hormoneschapter 36 ; Pregnancy in women with
SLE /Megan E.B. Clowsechapter 37 ; Neonatal lupus erythematosus /Marie Wahren-Herlenius,
Sven-Erik Sonesson, and Megan E.G. Clowsechapter 38 ; Reproductive and hormonal issues
in women with autoimmune diseases /Eliza F. Chakravarty
Section VI: Special considerations, subsets of SLE and lupus-related syndromeschapter
39 ; Drug-induced lupus: etiology, pathogenesis, and clinical aspects /Dipak Patel
and Bruce Richardsonchapter 40 ; SLE in childhood and adolescence /Thomas J.A. Lehmanchapter
41 ; Mixed connective tissue disease and undifferentiated connective tissue disease
/Robert W. Hoffman and Eric L. Greidingerchapter 42 ; Clinical aspects of the antiphospholipid
syndrome /Aisha Lateef and MIchelle Petri
Section VII: Assessment of lupuschapter 43 ; Clinical application of serologic tests,
serum protein abnormalities, and other clinical laboratory tests in SLE /Francisco
P. Quismorio, Jr., and Karina D. Torralbachapter 44 ; Differential diagnosis and disease
associations /Meenakshi Jolly, Serene Francis, and Winston Sequeirachapter 45 ; SLE
and infections /Judith A. James, Andrea L. Sestak, and Evan S. Vistachapter 46 ; Clinical
measures, metrics, and indices /Zahi Touma, Dafna D. Gladman, and Murray B. Urowitz
Section VIII: Managemen of SLEchapter 47 ; Principles of therapy, local measures,
and nonsteroidal medications /Mariko Ishimori, Michael H. Weisman, Katy Setoodeh,
and Daniel J. Wallacechapter 48 ; Systemic glucocorticoid therapy in SLE /Kyriakos
A. Kirou and Dimitrios T. Boumpaschapter 49 ; Antimalarial medications /J. Antonio
Aviña-Zubieta and John M. Esdailechapter 50 ; Immunosuppressive drug therapy /W. Joseph
McCune and Tania Gonzalez-Riverachapter 51 ; Specialized treatment approaches and
niche therapies for lupus /Daniel J. Wallacechapter 52 ; Adjunctive and preventive
measures /Diane L. Kamenchapter 53 ; Novel therapies for SLE: biological agents available
in practice today /Ronald F. van Vollenhovenchapter 54 ; Critical issues in drug development
for SLE /Ronald F. van Vollenhovenchapter 55 ; Socioeconomic and disability aspects
/Michael M. Ward
Section IX: Outcomes and future considerationschapter 56 ; Investigational agents
and future therapy for SLE /Georg H. Stummvoll and Josef S. Smolenchapter 57 ; Mortality
in SLE /Sasha Bernatsky, Deborah Levy, Rosalind Ramsey-Goldman, Caroline Gordon, Anisur
Rahman, and Ann E. ClarkeAppendix: Lupus resource materialsJenny Thorn Palter
